IGFBP3 and melanoma: Importantly, the signaling networks employed by the C2 IGFBP3+ subtype, particularly the PROS and MHC-II pathway, suggest a potential, unexplored role for this aggressive subtype in mediating neuro-immune crosstalk within the melanoma microenvironment.